Point-of-care drug monitoring system
The platform was developed to analyze minimal sample volumes of whole blood, urine, saliva, and fresh tissue samples (biopsy and tissue homogenate) to determine drug levels within minutes of blood collection. It is particularly useful for oncology patients who have been administered small-molecule chemotherapeutic agents.
Log in to use your Qmed Profile information. Don't have a Qmed Profile? Register Now.
